Evidence map›Paper›PMID 40303648›Full record

ArticleFrontiers in endocrinology2025

Corrigendum: The value of targeted CXCR4

Yushi Peng, Fangansheng Chen, Rui Yao, Junping Lan, Yinuo Fu, Kaifeng Ye, Zhiqiang Wang, Qianxiu Zhao, Xiaowei Ji, Kang Xia and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Yushi PengDepartment of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Fangansheng ChenDepartment of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Rui YaoDepartment of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Junping LanDepartment of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Yinuo FuThe First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, China.
Kaifeng YeThe First School of Clinical Medicine, Wenzhou Medical University, Wenzhou, China.
Zhiqiang WangDepartment of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Qianxiu ZhaoDepartment of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xiaowei JiDepartment of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Kang XiaDepartment of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Guoqing ZhuDepartment of Interventional Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Kewen ZhengDepartment of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xuemei Gu *Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Kun Tang *Department of Nuclear Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fendo.2025.1533295.].

Indexed as

18 F-pentixaforCXCR4PET/CTprimary aldosteronismsubtypingtreatment

Identifiers

PMID40303648
PMCPMC12039308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.